The ISSCR Announces Los Angeles, CA as the site of its 2019 annual meeting, noting that it's the first time the organization will be meeting in that city. ISSCR 2019 is expected to draw more than 3,000 stem cell researchers and professionals from around the globe to the Los Angeles Convention Center 26-29 June, 2019.

The ISSCR, the world’s largest professional organization of stem cell scientists, today released newly updated guidelines for stem cell research and the development of new clinical therapies. Guidance addresses key scientific, ethical, social, and policy challenges raised by new technologies and emerging areas of stem cell discovery and application.

The ISSCR announces an RFP for co-sponsorship of the 2021 annual meeting

The International Society for Stem Cell Research (ISSCR) is the world’s leading professional organization of stem cell scientists, representing more than 4,000 members in 45 U.S. states and 65 countries around the world. The ISSCR is opposed to recent efforts to inappropriately limit or prohibit biomedical research using fetal tissue. These proposals, if enacted, would obstruct critical biomedical research and inhibit efforts to improve human health. If enacted in the past, such limits would have delayed or prevented the development of therapies that have saved millions of lives.

The International Society for Stem Cell Research (ISSCR) is excited to announce the society’s 2016 award recipients, who will be formally recognized at its annual meeting, taking place 22-25 June, 2016 in San Francisco, California, U.S.

The ISSCR is announcing that Melbourne, Australia has been chosen as the location of its 2018 annual meeting.

Comments are now being accepted on the draft of the ISSCR's "Guidelines for Stem Cell Research and Clinical Translation." We encourage you to consider and provide feedback on this important document.

The ISSCR announces Sean J. Morrison, Children’s Research Institute at UT Southwestern Medical Center, as incoming president of the ISSCR board of directors, immediately following the ISSCR’s annual meeting, June 24-27, 2015.

In response to an article published by Chinese scientists describing research that used gene editing technologies in human embryos, the International Society for Stem Cell Research (ISSCR) has again called for a moratorium on attempts at human clinical germline genome editing while extensive scientific analysis of the potential risks is conducted, along with broad public discussion of the societal and ethical implications.

The ISSCR launched an expanded “Closer Look at Stem Cells” website (www.closerlookatstemcells.org), an online resource to help patients and their families make informed decisions about stem cell treatments, clinics and their health.

The International Society for Stem Cell Research calls for a moratorium on attempts at clinical application of nuclear genome editing of the human germ line to enable more extensive scientific analysis of the potential risks of genome editing and broader public discussion of the societal and ethical implications.

The ISSCR Announces Recipients of the 2015 McEwen Award for Innovation, the ISSCR-BD Biosciences Outstanding Young Investigator, and the ISSCR Public Service Awards

Q&A with Dr. Anthony Atala, director of Wake Forest Institute for Regenerative Medicine, North Carolina, U.S.A., and leader of the consortium of researchers that make up the Armed Forces Institute of Regenerative Medicine (AFIRM). He spoke about the organization and its mission.

With human embryonic stem cells as a starting point, the scientists are for the first time able to produce, in the kind of massive quantities needed for cell transplantation and pharmaceutical purposes, human insulin-producing beta cells equivalent in most every way to normally functioning beta cells.

Scientists at Boston Children’s Hospital, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Boston University have created a computer algorithm called CellNet as a “roadmap” for cell and tissue engineering, to ensure that cells engineered in the lab have the same favorable properties as cells in our own bodies.